Genetron rises on EU nod for multi-gene test

Genetron Holdings

01/06/2022 15:39

** U.S.-listed shares of Chinese medtech firm Genetron
Holdings Ltd  GTH.O  rise 8.6% to $1.51
    ** Co receives the European CE Mark for its FusionScan Plus
Kit used for simultaneously detecting multiple gene mutations
and fusions  urn:newsml:reuters.com:*:nGNX1Gnvzd
    ** CE mark indicates conformity with health, safety and
environmental protection standards for products sold within the
European Economic Area
    ** Stock down ~75% this year, including session moves

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))